Virtus Fund Advisers’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$8.23M	Buy	68,801 +6,608	+11%	+$805K	0.08%	197
2017 Q3	$8.72M	Sell	62,193 -72,463	-54%	-$9.84M	0.09%	198
2017 Q2	$16.6M	Sell	134,656 -15,663	-10%	-$1.82M	0.16%	184
2017 Q1	$18.2M	Sell	150,319 -1,466	-1%	-$189K	0.17%	177
2016 Q4	$18.6M	Sell	151,785 -5,370	-3%	-$657K	0.16%	172
2016 Q3	$19.3M	Buy	157,155 +6,848	+5%	+$881K	0.17%	164
2016 Q2	$17.8M	Sell	150,307 -2,838	-2%	-$403K	0.16%	168
2016 Q1	$21.3M	Buy	153,145 +2,194	+1%	+$322K	0.19%	166
2015 Q4	$28.8M	Buy	150,951 +379	+0.3%	+$66.2K	0.25%	132
2015 Q3	$23.5M	Sell	150,572 -2,443	-2%	-$446K	0.21%	142
2015 Q2	$27.7M	Buy	153,015 +1,003	+0.7%	+$173K	0.21%	141
2015 Q1	$26.3M	Sell	152,012 -48,843	-24%	-$8.84M	0.2%	145
2014 Q4	$37.2M	Buy	200,855 +4,131	+2%	+$765K	0.27%	131
2014 Q3	$32.6M	Sell	196,724 -2,584	-1%	-$424K	0.25%	140
2014 Q2	$31.1M	Buy	+199,308	New	+$31.5M	0.22%	163